Clinical Trial Update: Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease [NA]

View source ↗

Summary

Clinical trial update for rifaximin in treating persistent symptoms in patients with celiac disease; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Columbia University | Conditions: Celiac Disease | NA | Status: COMPLETED | Results posted: 2022-06-29